Market Overview
The Australia MedTech market was valued at USD 8.48 Billion in 2024, and is expected to reach USD 13.90 Billion by 2033, at a CAGR of 5.10% during the forecast period 2025-2033. The market growth is accelerated by demand for advanced healthcare technology from the aging population and rising prevalence of chronic diseases, with support from government initiatives and a strong innovation ecosystem. New South Wales dominates through access to healthcare infrastructure and research, and government investment in innovation. For more details, visit the Australia MedTech Market.
How AI is Reshaping the Future of Australia MedTech Market:
- These limitations could be addressed using artificial intelligence algorithms in molecular medicine to increase the accuracy of molecular diagnostics.
- A new accelerator program in Australia provides data and AI services to innovative, data-driven MedTech companies to drive biomedical innovation.
- Robots and artificial intelligence (AI) healthcare technology can do less intrusive surgeries and procedures with a greater degree of accuracy, and faster recovery times.
- AI applications in health care practice management can help to optimize operations and free time for administrators and staff for patient care.
- AI-based data analytics advances allow health management applications to become predictive to assist in preventive/personalized care delivery and clinical decision-making.
- Government grants and funding enable faster implementation of AI in clinical trials and products, helping the MedTech startups innovation process.
Grab a sample PDF of this report: https://www.imarcgroup.com/australia-medtech-market/requestsample
Market Growth Factors
Aging of the Australian population is also a key driver of the MedTech market, with the increased longevity of the Australian population resulting in greater demand for pacemakers, orthopedic implants and assistive devices to treat the large number of Australians afflicted with chronic diseases such as cardiovascular disease and diabetes. Changes in the healthcare system towards preventative and personalized medicine to improve quality of life are also a driver of the market. These factors, and the growing need for monitoring and active specialist care, make the development of new medical products that enable independent living and remote monitoring of patients essential for the market.
Higher public and private spending on healthcare drives the adoption of MedTech devices in Australia, where government has initiated programs to modernize hospitals and embrace digital health solutions. Private healthcare providers invest considerably in imaging systems, surgical robotics, and other capital equipment, which helps improve patient care and operational efficiencies. Expanding insurance coverage for imaging services is driving market growth. These aspects help to develop a conducive ecosystem for sustained growth, helped by local manufacturing and international collaborations.
Universities, startups and hospitals work together to create a collaborative research and development ecosystem in Australia’s MedTech sector, while existing clinical trial infrastructure allows for clinical adoption of new medical technologies. Universities work with industry to create new imaging technologies, diagnostics, implantable devices, and AI applications for health care. Government funding and innovation grants support development of products for both domestic and international markets. A high performing commercialization ecosystem will position Australia as a world leader in MedTech innovation, improving our global advantage.
Market Segmentation
Type:
- Telehealth
- Medical Wearables
- EMR/EHR Systems
- Medical Apps
- Healthcare Analytics
- Others
Component:
- Software
- Hardware
- Service
- Deployment Type:
- On-Premises
- Cloud-Based
Application:
- Cardiology
- Diabetes
- Neurology
- Sleep Apnea
- Oncology
- Others
End User:
- Healthcare Providers
- Healthcare Payers
- Pharmaceutical Companies
Region:
- Western Australia
- New South Wales
- Queensland
- Victoria
- Rest of Australia
Key Players
- Alcidion Group Limited
- Anatomics Pty Ltd
- Artrya
- AusBiotech
- Avanade Australia (Accenture)
- Cochlear Limited
- Ellex
- ResMed Inc.
- Schott AG
- Sirtex Medical Limited
Recent Development & News
- In April 2025, Avanade launched Avanade X in Australia to extend its digital consultancy and design capabilities, which build digital products and experiences using Microsoft’s technologies to implement solutions for customers and employees at scale.
- As of June 2025, the Australian government has focused partnerships between the education section and industry, focusing mainly on digital health/research/innovation, increasing start-up investments and collaborating with industry partners as key initiatives.
- In September 2025, Alcidion won an agreement with several healthcare networks to improve their digital maturity and management of clinical tasks, showing the growing trend to use integrated MedTech solutions within healthcare systems.
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us
- IMARC Group,
- 134 N 4th St. Brooklyn, NY 11249, USA,
- Email: [email protected],
- Tel No: (D) +91 120 433 0800,
- United States: +1-201971-6302